Survival in cardiac resynchronization therapy. What do we know?
- PMID: 17584682
Survival in cardiac resynchronization therapy. What do we know?
Abstract
Patients with moderate or severe heart failure often have some form of intraventricular conduction abnormality and increased QRS duration on the routine electrocardiogram. The most common pattern is the left bundle branch block, when the electrical activation of both ventricles is disturbed and the lateral wall of the left ventricle is significantly delayed. The use of cardiac pacing to coordinate the impaired electrical activation and myocardial contraction is called cardiac resynchronization therapy (CRT). Randomized trials of cardiac resynchronization were demonstrated to improve left ventricular systolic function, exercise tolerance, quality of life, and reduction in rehospitalization frequency of the patients. Resynchronization also prolongs survival in patients with NYHA Class III or IV heart failure and left ventricular ejection fraction =or<35%. Recent developments using electro-anatomic mapping, contact and noncontact endocardial mapping have demonstrated that the correct positioning of the pacing electrodes provides better resynchronization and better response to CRT. Body surface potential mapping and noninvasive electrocardiographic imaging provide also a deeper insight into the mechanism of cardiac electrical depolarization and contributing to develop the selection method of best pacing sites for patients referred for CRT.
Similar articles
-
Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Interact Cardiovasc Thorac Surg. 2008. PMID: 18541605 Review.
-
Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy?Indian Heart J. 2003 Nov-Dec;55(6):619-23. Indian Heart J. 2003. PMID: 14989512
-
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.Am J Cardiol. 2007 Jul 1;100(1):90-3. doi: 10.1016/j.amjcard.2007.02.058. Epub 2007 May 15. Am J Cardiol. 2007. PMID: 17599447 Clinical Trial.
-
Cardiac resynchronization therapy: device-based medicine for heart failure.J Card Surg. 2004 May-Jun;19(3):270-4. doi: 10.1111/j.0886-0440.2004.04081.x. J Card Surg. 2004. PMID: 15151661 Review.
-
Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.J Med Assoc Thai. 2007 Jul;90(7):1458-66. J Med Assoc Thai. 2007. PMID: 17710992
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials